New onset psoriasis in a patient receiving abatacept for rheumatoid arthritis

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Jost, Christina ^a   Hermann, Josef ^a   Caelen, Laila El Shabrawi ^a   Graninger, Winfried ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82355162998     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.09.2008.0845     Document Type: Article

References (9)

1. Genovese MC, Schiff MM, Luggen M, et al. Efficacy and safety of the selective co-stimulation modulator abatacept following two years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy. Ann Rheum Dis 2008; 67: 547-54. [Abstract/FREE Full text] (Pubitemid 351498439)
2. Weisman MH. J Rheumatol 2006; 33: 2162-6. [Abstract/FREE Full text]
3. Kremer JM, Dougados M, Emery P, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve months results of a phase IIb, double blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52: 2263-71. [CrossRef] [Medline] [Web of Science] (Pubitemid 41117408)
4. Schön MP, Boehnke WH. Psoriasis. N Engl J Med 2005; 352: 1899-12. [CrossRef ] [Medline] [Web of Science]
5. Lebwohl M. Psoriasis. Lancet 2003; 361: 1197-204. [CrossRef] [Medline] [Web of Science]
6. Abrams JR, Kelley SL, Hayes E, et al. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med 2000; 192: 681-94. [Abstract/FREE Full text]
7. Abrams JR, Lebwohl MG, Guzzo CA, et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999; 103: 1243-52. [Medline] [Web of Science] (Pubitemid 29218294)
8. Albanesi C, De Pita' O, Girolomoni G. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol 2007; 25: 581-8. [CrossRef] [Medline] [Web of Science] (Pubitemid 350087605)
9. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review. Semin Arthritis Rheum 2008; 37: 251-5. [CrossRef] [Medline] [Web of Science]